Beligas Pharmaceutical Human Growth Hormone 10IUx 10 Pen Style Cartridge Beligas

Research Compound OverviewBeligas Pharmaceutical Human Growth Hormone is a recombinant somatotropin formulation supplied in convenient pen-style cartridges for laboratory research applications. This growth hormone preparation contains 10IU per cartridge in a sterile, pharmaceutical-grade solution optimised for in-vitro studies examining growth factor signalling pathways, protein synthesis mechanisms, and metabolic regulation processes. The pen-style delivery system provides precise dosing control for experimental protocols requiring accurate compound administration in research settings.Each cartridge contains biosynthetic human growth hormone identical in amino acid sequence to endogenous somatotropin, manufactured using recombinant DNA technology. This compound represents a critical research tool for investigating the complex physiological pathways mediated by growth hormone receptors in cellular and tissue models. Research teams at steroidsshopuk.co.uk frequently utilise this preparation alongside other compounds from our growth hormone collection for comprehensive endocrine research protocols.Laboratory Research ApplicationsThis recombinant growth hormone formulation enables researchers to investigate multiple aspects of somatotropin biology in controlled experimental environments. Studies commonly examine growth hormone’s role in protein synthesis regulation, lipolytic pathway activation, and IGF-1 signalling cascade modulation. The compound proves invaluable for research into growth factor receptor binding kinetics, post-receptor signalling mechanisms, and downstream metabolic effects in various cell culture systems.Research applications extend to examining growth hormone’s interaction with other endocrine pathways, particularly those involving insulin sensitivity, glucose homeostasis, and lipid metabolism. Scientists frequently incorporate this compound into studies alongside selective androgen receptor modulators and peptide compounds to investigate synergistic effects in metabolic research models. The pen-style cartridge format facilitates precise experimental dosing protocols while maintaining compound stability throughout extended research programmes.Technical SpecificationsBeligas Human Growth Hormone Research SpecificationsParameterSpecificationActive CompoundRecombinant Human Growth Hormone (Somatropin)Concentration10IU per cartridgeFormulationSterile solution in pen-style cartridgePurityPharmaceutical grade (verify with supplier)Molecular Weight22,124 DaAmino Acid Sequence191 amino acids (identical to endogenous hGH)Storage Temperature2-8°C (refrigerated)Shelf LifeVerify with manufacturer documentationResearch Compliance StatementThis Beligas Pharmaceutical Human Growth Hormone preparation is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic use, or any application outside controlled scientific investigation. Researchers must possess appropriate credentials and operate within institutional guidelines for handling recombinant biological compounds. The compound requires proper storage conditions, sterile handling techniques, and disposal according to laboratory safety protocols. All research applications must comply with relevant institutional ethics committees and regulatory frameworks governing growth hormone research in laboratory settings.